A detailed history of Founders Capital Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Founders Capital Management, LLC holds 3,000 shares of MRNA stock, worth $118,770. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,000
Previous 3,000 -0.0%
Holding current value
$118,770
Previous $356,000 43.82%
% of portfolio
0.04%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$101.21 - $166.61 $2,024 - $3,332
-20 Reduced 0.66%
3,000 $356,000
Q4 2022

Jan 20, 2023

BUY
$118.38 - $210.04 $357,507 - $634,320
3,020 New
3,020 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Founders Capital Management, LLC Portfolio

Follow Founders Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management, LLC with notifications on news.